Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

  • December 2019 •
  • 136 pages •
  • Report ID: 619256 •
  • Format: PDF
Report Scope:
This research report categorizes the market for sample preparation in genomics, proteomics and epigenomics by product segment.The major product segments are instruments, consumables, accessories and sample preparation kits.

The instruments segment is subdivided into workstations, liquid handling systems, extraction systems and other instruments.Consumables are divided into columns, filters, tubes, plates and other consumables.

Sample preparation kits are segmented into purification kits, isolation kits, extraction kits and others.

The global market for sample preparation is segmented by end user into research centers, academic institutes, and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies and others.The markets in North America, Europe, Asia-Pacific and rest of the world are covered.

The market is also segmented by application into genomics, proteomics and epigenomics.

Report Includes:
- 52 data tables and 36 additional tables
- An overview of the global market for sample preparation in genomics, proteomics and epigenomics within the life sciences sector
- Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Insight into the current state of the sample preparation industry with special focus on the genomics, epigenomics and proteomics product, application, and end user segments
- Description of labelling and probes in the sample preparation industry
- Detailed analysis of the competitive environments, and new potential markets for novel products and assay development
- Identification of future demand for various sample preparation reagents and products and analysis of target markets
- Comprehensive profiles of the major market players, including Bio-Rad Laboratories, Inc., Danaher Corp., Merck Millipore, PerkinElmer Inc., Qiagen GmbH and Thermo Fisher Scientific, Inc.

Summary
The completion of Human Genome Project in 2003 had major impact on the market for genomics, proteomics and epigenomics.Since then, the cost of sequencing has decreased substantially.

There has been increased interest in the fields of genomics and proteomics due to increasing applications in various fields.Epigenomics is part of genomics and is the most recent technique that has been applied successfully in cancer treatment.

Downstream processing in genomics and proteomics requires a sample that is free of impurities and in adequate quantities. Hence, sample preparation for these technologies is as important as the downstream processing.

Around 5 million scientists are working on biological sample preparation in more than REDACTED laboratories globally.The major factors impacting the market are increased spending on research and development in the developing economies, with China emerging as a global leader in sequencing, and an increasing number of genomics projects run by agencies throughout the globe to create genome libraries.

There has also been increased interest in personal genetics, with many companies, including Google, investing in genomics start-up companies.With the growth in genomics and proteomics, thereis growing concern regarding data security and privacy.

In addition, personal genomics kits currentlybeing sold directly to consumers have become a growing concern for the U.S. Food and DrugAdministration (FDA).

The global market for genomics and proteomics is huge, and sample preparation is a subsegment of it.

The major market drivers are increasing research and development, innovation and automation, demand for high quality samples, personal genomics and the high return on investment. The global market for sample preparation in genomics, proteomics and epigenomics is estimated to be valued at REDACTED in 2018 and is expected to reach REDACTED by 2024 at a CAGR of REDACTED.